摘要
目的:观察小剂量辛伐他丁(舒降之)对高脂血症的治疗效果。方法:选择78例原发性高脂血症,治疗前末用过降脂药物,治疗8周后观察治疗前后血清TC、TG、LDL-C、HDL-C浓度变化。结果:与治疗前相比,TC下降23.77%、TG下降39.18%、LDL-C下降38.24%、HDL-C浓度上升27.55%。有效率分别为:88.46%、78.21%、80.77%、70.51%。结论:辛伐他丁对轻中度原发性高血脂症降脂效果显著。高脂血症是冠心病、高血压的主要危险因素之一,血脂水平维持在正常范围能预防和降低冠心病的患病率和病死率,降低心血管事件的发病率。现对78例原发性高脂血症患者应用小剂量辛伐他丁治疗效果进行观察。
Objective： to observe small dose simastatin butyl （hsu drop） for the treatment of hyperiipidcmia effect. Methods： choose 78 cases of primary hyperlipidemia, at the end of the before treatment with lipid-lowering drugs, treatment after eight weeks observed before and af- ter treatment serum TC, TG, LDL - C, hdl-c concentration change. Results： compared with before treatment, TC, TG fell 23.77%, 39.18% decline LDL - C drop 38.24%, hdl-c concentration increased by 27.55%. Efficient were 88.46%, 78.21%, 80.77%, 70.51%.Conclusion： mild-moderate donor butyl simastatin of primary hyperlipidemia lipid-lowering effect is remarkable.Coronary heart disease, hypertension hy- perlipidemia is one of the risk factors of, lipid levels in maintaining normal range can prevent and reduce the morbidity and mortality of coronary heart disease, reduce the incidence of cardiovascular events. Now in 78 cases of primary hyperlipidemia patients applied small dose simastatin butyl treatment effect were observed.
出处
《内蒙古中医药》
2012年第23期36-37,共2页
Inner Mongolia Journal of Traditional Chinese Medicine
关键词
辛伐他丁
高脂血症
观察
simastatin
hyperlipidemia observation
